Nurix Therapeutics (NRIX) Assets Growth (5y) (2024 - 2026)
Powered by 
Analysis
Nurix Therapeutics (NRIX) Assets Growth (5y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.83 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.33 Bn | 32.03 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.36 Bn | 27.52 Bn | - |
| 9 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn |
| 10 | Nurix Therapeutics | 2.86 Bn | 2.42 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 0.67% |
| Feb 28, 2026 | 9.91% |
| Nov 30, 2025 | 11.67% |
| Aug 31, 2025 | 4.87% |
| Nov 30, 2024 | 72.32% |